Recent News

• 11.02.2026 - Danaher to Present at UBS Global and Jefferies Global Healthcare Conferences
• 10.21.2026 - Danaher Reports Third Quarter 2026 Results
• 10.14.2026 - Danaher Collaborates with NVIDIA to Advance Autonomous Science
• 10.12.2026 - Danaher Announces Appointments of Daniel Comas and Robert Hershberg to Board of Directors
• 10.07.2026 - Danaher Accelerates Life Sciences Research with New AI-powered Autonomous Lab
• 10.01.2026 - Julie Sawyer Montgomery Assumes Role as Danaher President and Chief Executive Officer
• 09.22.2026 - Danaher Schedules Third Quarter 2026 Earnings Conference Call
• 09.15.2026 - Danaher Announces Quarterly Dividend
• 08.03.2026 - Danaher Appoints Julie Sawyer Montgomery as President and Chief Executive Officer
• 07.21.2026 - Danaher Reports Second Quarter 2026 Results

Recent Filings

• 11.02.2026 - 4 Statement of changes in beneficial ownership of securities
• 11.02.2026 - 4 Statement of changes in beneficial ownership of securities
• 11.02.2026 - 4 Statement of changes in beneficial ownership of securities
• 11.02.2026 - 4 Statement of changes in beneficial ownership of securities
• 11.02.2026 - 4 Statement of changes in beneficial ownership of securities
• 11.02.2026 - 4 Statement of changes in beneficial ownership of securities
• 11.02.2026 - 4 Statement of changes in beneficial ownership of securities
• 10.29.2026 - 4 Statement of changes in beneficial ownership of securities
• 10.29.2026 - 4 Statement of changes in beneficial ownership of securities
• 10.28.2026 - 144 Report of proposed sale of securities